Mass Spectrometric, Immunoglobulins (G, A, M, D, E)
SGG · Class II — Moderate Risk (510(k) clearance required) · Immunology · 21 CFR 866.5510
Classification
FDA Product Code
SGG
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.5510
Review panel
IM
Medical specialty
Immunology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
The test system is intended for the (semi-)quantitative or quantitative determination of monoclonal immunoglobulins (M-proteins) and/or the identification of Immunoglobulin isotype of M-proteins in human specimens by mass spectrometric methods.